InfuSystem Holdings, IncINFU

NYSEHealthcareSurgical & Medical Instruments & Apparatus
Price (close)
$12.69
Market cap
$252.7M
P/E
29.6x
Revenue (TTM)
$143.3M
Net income
$8.5M
Dividend yield
—
1-year total return
25.9%
Net margin
6.0%
Revenue growth
2.5%
Debt / equity
0.35x

What InfuSystem Holdings, Inc does.

InfuSystem Holdings, Inc. ("we," "us," "our" or the "Company") is a Delaware corporation. Formed in 2005, the Company operates through its subsidiary InfuSystem, Inc., a Delaware corporation ("InfuSystem" or "ISI").

We are a leading national healthcare service provider, facilitating outpatient care for Durable Medical Equipment (DME) manufacturers and healthcare providers. We provide our products and services to hospitals, oncology practices, ambulatory surgery centers, and other alternate site healthcare providers. Our headquarters is in Rochester Hills, Michigan, and we operate our business from a total of seven locations in the United States ("U.S.") and Canada.

Our lead platform, Patient Services, provides last-mile solutions for clinic-to-home healthcare where the continuing treatment involves complex DME and related services.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue$97.4M$102.4M$109.9M$125.8M$134.9M$143.4M
Net income$17.3M$1.4M$18,000$872,000$2.3M$6.6M
Free cash flow$19.2M$17.3M$16.5M$10.2M$19.4M$23.8M

More on INFU.

Figures from InfuSystem Holdings, Inc's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.